SSA
SOPH icon

Schonfeld Strategic Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-61,200
Closed -$302K – 2539
2024
Q1 		$302K Buy
61,200
+21,000
+52% +$101K ﹤0.01% 1642
2023
Q4 		$189K Buy
+40,200
New +$150K ﹤0.01% 1544

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Schonfeld Strategic Advisors's SOPH Position: Q2 2024 in Review

Schonfeld Strategic Advisors sold out of SOPHiA GENETICS (SOPH) in Q2 2024, closing a stake of 61,200 shares — an estimated $302K sold.

Schonfeld Strategic Advisors first reported a position in SOPH in Q4 2023 and held it in 2 quarters. The position peaked at $302K in Q1 2024. 31 funds tracked by Wall St. Rank hold SOPH as of Q2 2024.

  • Schonfeld Strategic Advisors reported no remaining SOPHiA GENETICS position as of Q2 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 61,200 SOPHiA GENETICS shares in Q2 2024, an estimated $302K.
  • Schonfeld Strategic Advisors first reported a position in SOPHiA GENETICS in Q4 2023 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's SOPHiA GENETICS position peaked at $302K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.